Emil Say to Vision Disorders
This is a "connection" page, showing publications Emil Say has written about Vision Disorders.
Connection Strength
0.026
-
Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma. Ophthalmology. 2014 Jan; 121(1):269-275.
Score: 0.026